Cathay Biotech (SHSE:688065) Total Liabilities : ¥3,341 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Total Liabilities?

Cathay Biotech's Total Liabilities for the quarter that ended in Sep. 2024 was ¥3,341 Mil.

Cathay Biotech's quarterly Total Liabilities declined from Mar. 2024 (¥3,753.84 Mil) to Jun. 2024 (¥3,432.10 Mil) and declined from Jun. 2024 (¥3,432.10 Mil) to Sep. 2024 (¥3,340.85 Mil).

Cathay Biotech's annual Total Liabilities increased from Dec. 2021 (¥1,510.77 Mil) to Dec. 2022 (¥2,789.07 Mil) and increased from Dec. 2022 (¥2,789.07 Mil) to Dec. 2023 (¥4,060.26 Mil).

Cathay Biotech Total Liabilities Historical Data

The historical data trend for Cathay Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Total Liabilities Chart

Cathay Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,339.92

650.74

1,510.77

2,789.07

4,060.26

Cathay Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															3,531.01	4,060.26	3,753.84	3,432.10	3,340.85

Cathay Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cathay Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3409.753	+	(245.332	+	405.178
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4,060

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	18833.373	-	14773.11
	=	4,060

Cathay Biotech's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2374.106	+	(572.015	+	394.731
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,341

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	18330.036	-	14989.184
	=	3,341

Cathay Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cathay Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.cathaybiotech.com

Cathay Biotech Inc is engaged in Research, development, production and sales of new bio-based materials.

Cathay Biotech Headlines

No Headlines